http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013129319-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6107abcc76ad54b3821249d6315e0ab
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
filingDate 2013-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_800630af540a446687455dca27d51181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7291a6748f55bb51aa29bf01550199e2
publicationDate 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2013129319-A1
titleOfInvention Ophthalmic composition
abstract An ophthalmic composition containing a geranylgeranylacetone and a phosphoric acid buffering agent has an extremely small decline in the content of the geranylgeranylacetone when the composition is stored for a long period of time because the adsorption of the geranylgeranylacetone into an ophthalmic container wall is inhibited. Moreover, the geranylgeranylacetone in the ophthalmic composition containing the geranylgeranylacetone and the phosphoric acid buffering agent is hardly adsorbed into a contact lens. Additionally, the ophthalmic composition containing the geranylgeranylacetone and the phosphoric acid buffering agent is less likely to become cloudy when being stored at low temperatures.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015029924-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015029926-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5483513-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014129466-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015029923-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014185139-A
priorityDate 2012-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0418015-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005298452-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000319170-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011515393-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000258735-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08133967-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17940481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128113704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226521381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226521383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226521382

Total number of triples: 38.